Motor cortex stimulation in rats with chronic constriction injury

Area of Science:

• Neuroscience
• Pain Management
• Neurology

Background:

• Neuropathic pain is a debilitating condition.
• Motor cortex stimulation (MCS) is an emerging treatment for neuropathic pain.
• Understanding MCS effects in animal models is crucial for clinical translation.

Purpose of the Study:

• To evaluate the efficacy of Motor Cortex Stimulation (MCS) in an experimental rat model of neuropathic pain.
• To investigate the influence of stimulation laterality (contralateral vs. ipsilateral) and duration (short-term vs. long-term) on pain relief.

Main Methods:

• Neuropathic pain was induced in rats via Chronic Constriction Injury (CCI) of the sciatic nerve.
• Thermal nociceptive thresholds of both hind limbs were measured before and after varying durations and laterality of MCS.
• Pain reduction was assessed by the difference score (paw withdrawal latency between ligated and non-ligated limbs).

Main Results:

• MCS did not alter pain thresholds in control rats.
• In CCI rats, both short-term and long-term contralateral MCS significantly reduced the pain difference score.
• Long-term ipsilateral MCS showed no significant difference compared to intact animals.
• Contralateral short-term and ipsilateral long-term MCS effects diminished within 1 hour.
• Contralateral long-term MCS effects persisted for over 1 hour and faded within 24 hours.

Conclusions:

• Motor Cortex Stimulation (MCS) demonstrates efficacy in reducing neuropathic pain in experimental animals.
• Contralateral, long-term MCS offers the most sustained pain relief in this model.
• These findings suggest MCS may be a viable therapeutic strategy for neuropathic pain, potentially engaging both cerebral cortices.